Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Drug Delivery
Sun Pharma enters definitive financial agreement with Concert
Concert stockholders will also receive a tradable contingent value right (CVR) entitling holders to receive up to an additional $3.50 per share of common stock in cash
Ingredients
Sun Pharma questions pandemic effects on business
Director has said performance reflects the impact of the global COVID-19 pandemic but vertical integration has benefitted supply chain for formulations
Finance
Sun Pharma licenses seven generics to Chinese company
China Medical System Holdings subsidiary will develop and commercialise the Indian company's seven generic products for Mainland China
Finance
Sun Pharma to operate manufacturing plants in Japan
India's drugmaker taps into dermatology market with acquisition of Japan-based Pola Pharma
Pharmaceutical
Sun Pharma opens new cGMP production line in India
The Mumbai-based company has installed a production line in Guwahati to enhance the manufacturing capacity of sterile products
Regulatory filing of tildrakizumab in Europe
Potential of tildrakizumab for patients with moderate-to-severe plaque psoriasis, without burden of frequent injections
Finance
Almirall pays Sun Pharma $50 million upfront in licensing deal for psoriasis treatment in Europe
Phase III clinical trials of tildrakizumab were completed in May, with positive results
Subscribe now